Essilor International climbs on Forbes’ list
Monday, September 16 2013 | 00 h 00 min | News
Essilor International is up five spots and now ranks 23rd on Forbes Magazine’s list of the 100 most innovative companies in 2013.
For Forbes, the most innovative companies are those that are most likely to succeed in the future. Essilor International ranks as the 5th most innovative company in Europe, and the 2nd most innovative in France. The magazine based this ranking on the more than $200 million that Essilor invests in R&D each year, its three Innovation and Technology Centres and its 500 researchers on various continents. Approximately 40% of Essilor’s annual sales are generated from products launched over the last three years.
Quebec-based Valeant Pharmaceuticals, which recently acquired Bausch+Lomb, ranks 62nd. The company, whose sales have increased by over 36% in the 12 months preceding the release of the list, is the only Canadian company to be included on the list.
Other industry players are also named, such as Regeneron (4th), whose drug Eylea is a major competitor for Lucentis in the treatment of AMD, and might also be used to treat diabetic macular edema. LVMH Moet Hennessy Louis Vuitton came in 75th place, whereas adidas is in 92nd place.